Literature DB >> 9790747

Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)).

J Gelernter1, H Kranzler, J Lacobelle.   

Abstract

We determined allele frequencies for polymorphisms at several loci of interest in neuropsychiatry-tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), ciliary neurotrophic factor (CNTF), and the mu opioid receptor (OPRM1)-in samples of individuals from populations in several different parts of the world. Associations with psychiatric illness have been proposed for specific polymorphisms at TPH (suicide-related behaviors and impulsivity), DRD3 (schizophrenia and bipolar affective disorder), SLC6A3 (susceptibility to cocaine-induced paranoia and attention-deficit disorder), CNTF (psychosis), and OPRM1 (substance dependence). APOE alleles are related to risk of Alzheimer disease. We found significant allele frequency variation among populations at all six loci. These results will provide a global framework of normal variation at these loci that might have functional significance or otherwise be related to susceptibility to various disorders or behavioral phenomena. Knowledge of this variation can be important for study design and data interpretation when individuals from various population groups are research subjects and may eventually help lead to a better understanding of behavioral adaptation. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790747     DOI: 10.1006/geno.1998.5454

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  7 in total

Review 1.  Further clarification of the contribution of the tryptophan hydroxylase (TPH) gene to suicidal behavior using systematic allelic and genotypic meta-analyses.

Authors:  Dawei Li; Lin He
Journal:  Hum Genet       Date:  2006-02-01       Impact factor: 4.132

Review 2.  Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Gwynne L Davis; Tammy N Jessen; Jane Wright; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Neurochem Int       Date:  2013-12-08       Impact factor: 3.921

3.  Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene.

Authors:  D A Nickerson; S L Taylor; S M Fullerton; K M Weiss; A G Clark; J H Stengård; V Salomaa; E Boerwinkle; C F Sing
Journal:  Genome Res       Date:  2000-10       Impact factor: 9.043

4.  Dopamine transporter (DAT1) VNTR polymorphism in 12 Indian populations.

Authors:  L V K S Bhaskar; Kumarasamy Thangaraj; Connie J Mulligan; Samiksha Wasnik; Amrita Nandan; Varun Kumar Sharma; Vishwas Sharma; Alla Govardhana Reddy; Lalji Singh; Vadlamudi Raghavendra Rao
Journal:  Neurol Sci       Date:  2009-09-25       Impact factor: 3.307

Review 5.  Neurobiology of aggression and violence.

Authors:  Larry J Siever
Journal:  Am J Psychiatry       Date:  2008-03-17       Impact factor: 18.112

6.  DAT genotype modulates brain and behavioral responses elicited by cigarette cues.

Authors:  Teresa R Franklin; Falk W Lohoff; Ze Wang; Nathan Sciortino; Derek Harper; Yin Li; Will Jens; Jeffrey Cruz; Kyle Kampman; Ron Ehrman; Wade Berrettini; John A Detre; Charles P O'Brien; Anna Rose Childress
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

7.  Molecular variation at the SLC6A3 locus predicts lifetime risk of PTSD in the Detroit Neighborhood Health Study.

Authors:  Shun-Chiao Chang; Karestan C Koenen; Sandro Galea; Allison E Aiello; Richelo Soliven; Derek E Wildman; Monica Uddin
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.